MEROPENEM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Meropenem, and when can generic versions of Meropenem launch?
Meropenem is a drug marketed by Acs Dobfar, Acs Dobfar Spa, Amneal Pharms, Brooks Steriscience, Daewoong Pharm Co, Eugia Pharma, Gland, Hospira Inc, Hq Spclt Pharma, Qilu, Sandoz, Savior Lifetec Corp, and B Braun Medical. and is included in fifteen NDAs.
The generic ingredient in MEROPENEM is meropenem. There is one drug master file entry for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the meropenem profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Meropenem
A generic version of MEROPENEM was approved as meropenem by ACS DOBFAR on October 26th, 2011.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MEROPENEM?
- What are the global sales for MEROPENEM?
- What is Average Wholesale Price for MEROPENEM?
Summary for MEROPENEM
| US Patents: | 0 |
| Applicants: | 13 |
| NDAs: | 15 |
| Finished Product Suppliers / Packagers: | 17 |
| Raw Ingredient (Bulk) Api Vendors: | 72 |
| Clinical Trials: | 161 |
| Patent Applications: | 5,335 |
| Drug Prices: | Drug price information for MEROPENEM |
| What excipients (inactive ingredients) are in MEROPENEM? | MEROPENEM excipients list |
| DailyMed Link: | MEROPENEM at DailyMed |
Recent Clinical Trials for MEROPENEM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| The Swedish Research Council | PHASE4 |
| Uppsala University | PHASE4 |
| Uppsala Clinical Research Center, Sweden | PHASE4 |
Pharmacology for MEROPENEM
| Drug Class | Penem Antibacterial |
Anatomical Therapeutic Chemical (ATC) Classes for MEROPENEM
US Patents and Regulatory Information for MEROPENEM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B Braun Medical | MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER | meropenem | POWDER;INTRAVENOUS | 202106-001 | Apr 30, 2015 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Acs Dobfar | MEROPENEM | meropenem | INJECTABLE;INJECTION | 091404-002 | Oct 26, 2011 | AP | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Hq Spclt Pharma | MEROPENEM | meropenem | INJECTABLE;INJECTION | 210773-001 | Aug 16, 2019 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
